Literature DB >> 7587428

Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases.

Y Mizushima1, M Kobayashi.   

Abstract

To define the clinical characteristics of multiple lung cancer (LC) associated with idiopathic pulmonary fibrosis (IPF), we reviewed 154 LC patients associated with IPF: 23 patients with synchronous multiple LC (IPF-multiple LC group) and 131 with single LC (IPF-single LC group), and these were compared with 4,931 patients with LC from 1975 to 1977 in Japan (whole LC group). In the IPF-single and IPF-multiple LC groups, most tumors were observed in male patients (91% and 96%), smokers (94% and 100%), and in peripheral regions of the lung (91% and 98%). The incidence of occurrence in the lower lobes, where a fibrotic shadow was prominent, was significantly higher in the IPF-LC groups (58% and 67%) than for the whole LC group (37%). The distribution of histologic types in the IPF-single LC group was similar to that of the whole LC group. However, the incidence of small cell carcinoma was significantly higher in the IPF-multiple LC group (33%) than for the IPF-single LC (14%) and whole LC (12%) groups. These results indicate that the features characteristic to synchronous multiple LC in patients with IPF are as follows: (1) male patients; (2) smokers; (3) small cell carcinoma histologic type; (4) lower lobes; and (5) peripheral type, all of which show a high rate of occurrence.

Entities:  

Mesh:

Year:  1995        PMID: 7587428     DOI: 10.1378/chest.108.5.1272

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.

Authors:  Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 3.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis.

Authors:  K A Khan; M P Kennedy; E Moore; L Crush; S Prendeville; M M Maher; L Burke; M T Henry
Journal:  Lung       Date:  2014-11-09       Impact factor: 2.584

Review 5.  High-resolution CT of complications of idiopathic fibrotic lung disease.

Authors:  C R Lloyd; S L F Walsh; D M Hansell
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

Review 6.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

7.  Lung cancer risk in workers exposed to poly(vinyl chloride) dust: a nested case-referent study.

Authors:  G Mastrangelo; U Fedeli; E Fadda; G Milan; A Turato; S Pavanello
Journal:  Occup Environ Med       Date:  2003-06       Impact factor: 4.402

8.  Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.

Authors:  Taichiro Goto; Arafumi Maeshima; Yoshitaka Oyamada; Ryoichi Kato
Journal:  Int J Clin Oncol       Date:  2013-05-10       Impact factor: 3.402

Review 9.  Lung cancer in never smokers-the East Asian experience.

Authors:  Fei Zhou; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2018-08

Review 10.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.